Join Dr. Faisal Saghir, Hematology and Medical Oncology, Northwestern Medicine Regional Medical Group, for an informative discussion about the hormone therapies "tamoxifen" and "aromatase inhibitors," and the pros and cons of each therapy for the treatment of breast cancer.
► Follow us on / livingwellcrc and livingwellcrc.org to keep up to date on all LivingWell programming.
1 дек 2020
